Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Scott Kinlay, Ph.D., M.B.,B.S.

Concepts

This page shows the publications Scott Kinlay has written about Middle Aged.
Connection Strength

0.288
  1. Premature Discontinuation of Dual Antiplatelet Therapy After Coronary Stenting in Veterans: Characteristics and Long-Term Outcomes. J Am Heart Assoc. 2021 05 04; 10(9):e018481.
    View in: PubMed
    Score: 0.020
  2. Reproducibility and validity of a novel invasive method of assessing peripheral microvascular vasomotor function. PLoS One. 2019; 14(1):e0211152.
    View in: PubMed
    Score: 0.017
  3. Long-term outcomes in patients with acute coronary syndromes related to prolonging dual antiplatelet therapy more than 12 months after coronary stenting. Catheter Cardiovasc Interv. 2017 Jun 01; 89(7):1176-1184.
    View in: PubMed
    Score: 0.015
  4. Long-Term Outcomes in Patients With Diabetes Mellitus Related to Prolonging Clopidogrel More Than 12 Months After Coronary Stenting. J Am Coll Cardiol. 2015 Sep 08; 66(10):1091-101.
    View in: PubMed
    Score: 0.014
  5. Outcomes with prolonged clopidogrel therapy after coronary stenting in patients with chronic kidney disease. Heart. 2015 Oct; 101(19):1569-76.
    View in: PubMed
    Score: 0.014
  6. Prolonged clopidogrel use after bare metal and drug-eluting stent placement: the Veterans Administration drug-eluting stent study. Circ Cardiovasc Interv. 2012 Jun; 5(3):372-80.
    View in: PubMed
    Score: 0.011
  7. Percutaneous revascularization of long femoral artery lesions for claudication: patency over 2.5 years and impact of systematic surveillance. Catheter Cardiovasc Interv. 2011 Jun 01; 77(7):1055-62.
    View in: PubMed
    Score: 0.010
  8. Endogenous tissue plasminogen activator and risk of recurrent cardiac events after an acute coronary syndrome in the MIRACL study. Atherosclerosis. 2009 Oct; 206(2):551-5.
    View in: PubMed
    Score: 0.009
  9. Subclavian stenosis causing angina after coronary artery bypass grafting. Med J Aust. 2009 Mar 16; 190(6):331-2.
    View in: PubMed
    Score: 0.009
  10. Inflammation, statin therapy, and risk of stroke after an acute coronary syndrome in the MIRACL study. Arterioscler Thromb Vasc Biol. 2008 Jan; 28(1):142-7.
    View in: PubMed
    Score: 0.008
  11. Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study. Circulation. 2004 Jul 27; 110(4):386-91.
    View in: PubMed
    Score: 0.006
  12. Long-term effect of combined vitamins E and C on coronary and peripheral endothelial function. J Am Coll Cardiol. 2004 Feb 18; 43(4):629-34.
    View in: PubMed
    Score: 0.006
  13. High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study. Circulation. 2003 Sep 30; 108(13):1560-6.
    View in: PubMed
    Score: 0.006
  14. Comparison of effect of intensive lipid lowering with atorvastatin to less intensive lowering with lovastatin on C-reactive protein in patients with stable angina pectoris and inducible myocardial ischemia. Am J Cardiol. 2002 May 15; 89(10):1205-7.
    View in: PubMed
    Score: 0.005
  15. Relationship of clinical presentation and calcification of culprit coronary artery stenoses. Arterioscler Thromb Vasc Biol. 2001 Oct; 21(10):1618-22.
    View in: PubMed
    Score: 0.005
  16. Role of endothelin-1 in the active constriction of human atherosclerotic coronary arteries. Circulation. 2001 Sep 04; 104(10):1114-8.
    View in: PubMed
    Score: 0.005
  17. Usefulness of intravascular ultrasound in preventing stenting of hazy areas adjacent to coronary stents and its support of support spot-stenting. Am J Cardiol. 2001 Jun 01; 87(11):1246-9.
    View in: PubMed
    Score: 0.005
  18. Stent-Only Versus Adjunctive Balloon Angioplasty Approach for Saphenous Vein Graft Percutaneous Coronary Intervention: Insights From DIVA Trial. Circ Cardiovasc Interv. 2020 02; 13(2):e008494.
    View in: PubMed
    Score: 0.005
  19. Plasma alpha-tocopherol and coronary endothelium-dependent vasodilator function. Circulation. 1999 Jul 20; 100(3):219-21.
    View in: PubMed
    Score: 0.004
  20. Clinical Outcomes and Cost Comparisons of Stent and Non-Stent Interventions in Infrainguinal Peripheral Artery Disease: Insights From the Excellence in Peripheral Artery Disease (XLPAD) Registry. J Invasive Cardiol. 2019 01; 31(1):1-9.
    View in: PubMed
    Score: 0.004
  21. Comparison of different exercise ankle pressure indices in the diagnosis of peripheral artery disease. Vasc Med. 2018 12; 23(6):541-548.
    View in: PubMed
    Score: 0.004
  22. Identifying individuals with high fat levels and low P:S ratios, in their diets, for intensive dietary intervention. J Intern Med. 1997 May; 241(5):407-14.
    View in: PubMed
    Score: 0.004
  23. Risk of primary and recurrent acute myocardial infarction from lipoprotein(a) in men and women. J Am Coll Cardiol. 1996 Oct; 28(4):870-5.
    View in: PubMed
    Score: 0.004
  24. Effect of wetting the mouth on aortic blood pressure just before taking sublingual nitrates. Am J Cardiol. 1996 Sep 01; 78(5):555-8.
    View in: PubMed
    Score: 0.004
  25. Cardiac event recorders yield more diagnoses and are more cost-effective than 48-hour Holter monitoring in patients with palpitations. A controlled clinical trial. Ann Intern Med. 1996 Jan 01; 124(1 Pt 1):16-20.
    View in: PubMed
    Score: 0.004
  26. The cost-effectiveness of different blood-cholesterol-lowering strategies in the prevention of coronary heart disease. Aust J Public Health. 1994 Mar; 18(1):105-10.
    View in: PubMed
    Score: 0.003
  27. A new method of estimating cost effectiveness of cholesterol reduction therapy for prevention of heart disease. Pharmacoeconomics. 1994 Mar; 5(3):238-48.
    View in: PubMed
    Score: 0.003
  28. The effect of salsalate therapy on endothelial function in a broad range of subjects. J Am Heart Assoc. 2014 Jan 03; 3(1):e000609.
    View in: PubMed
    Score: 0.003
  29. Long-term outcomes of patients sent emergently to the catheterization laboratory for possible primary percutaneous coronary intervention. Am J Cardiol. 2013 Dec 01; 112(11):1745-9.
    View in: PubMed
    Score: 0.003
  30. Choice of anticoagulant affects measurement of plasma fibrinogen. Clin Chem. 1993 Aug; 39(8):1754-5.
    View in: PubMed
    Score: 0.003
  31. Comparison of clinical characteristics and outcomes of cardiac arrest survivors having versus not having coronary angiography. Am J Cardiol. 2013 May 01; 111(9):1253-8.
    View in: PubMed
    Score: 0.003
  32. Inflammatory biomarkers, death, and recurrent nonfatal coronary events after an acute coronary syndrome in the MIRACL study. J Am Heart Assoc. 2013 Jan 28; 2(1):e003103.
    View in: PubMed
    Score: 0.003
  33. Impact of door-to-activation time on door-to-balloon time in primary percutaneous coronary intervention for ST-segment elevation myocardial infarctions: a report from the Activate-SF registry. Circ Cardiovasc Qual Outcomes. 2012 Sep 01; 5(5):672-9.
    View in: PubMed
    Score: 0.003
  34. Electrocardiographic criteria for ST-elevation myocardial infarction in patients with left ventricular hypertrophy. Am J Cardiol. 2012 Oct 01; 110(7):977-83.
    View in: PubMed
    Score: 0.003
  35. Prevalence and factors associated with false-positive ST-segment elevation myocardial infarction diagnoses at primary percutaneous coronary intervention–capable centers: a report from the Activate-SF registry. Arch Intern Med. 2012 Jun 11; 172(11):864-71.
    View in: PubMed
    Score: 0.003
  36. Effect of processing time and storage on fibrinogen content of EDTA plasma assayed by radial immunodiffusion. Clin Chem. 1992 Jun; 38(6):1197.
    View in: PubMed
    Score: 0.003
  37. The validity of estimating heart disease reduction from a Framingham logistic equation. J Clin Epidemiol. 1992 May; 45(5):553-60.
    View in: PubMed
    Score: 0.003
  38. Delaying primary percutaneous coronary intervention for computed tomographic scans in the emergency department. Am J Cardiol. 2012 Aug 01; 110(3):345-9.
    View in: PubMed
    Score: 0.003
  39. Predictors of depressed left ventricular function in patients presenting with ST-elevation myocardial infarction. Am J Cardiol. 2012 Feb 01; 109(3):327-31.
    View in: PubMed
    Score: 0.003
  40. Percutaneous extraction of right atrial mass using the Angiovac aspiration system. J Vasc Interv Radiol. 2011 Sep; 22(9):1345-7.
    View in: PubMed
    Score: 0.003
  41. Lipid and apolipoprotein levels in an Australian community. Med J Aust. 1991 Feb 04; 154(3):170-5.
    View in: PubMed
    Score: 0.003
  42. Patterns of use of chest physiotherapy in a teaching hospital. Aust Clin Rev. 1991; 11(4):154-8.
    View in: PubMed
    Score: 0.002
  43. Use of real-time 3D transesophageal echocardiography in percutaneous intervention of a flush-occluded pulmonary vein. Circ Cardiovasc Interv. 2010 Aug; 3(4):394-5.
    View in: PubMed
    Score: 0.002
  44. Effectiveness and hazards of case finding for a high cholesterol concentration. BMJ. 1990 Jun 16; 300(6739):1545-7.
    View in: PubMed
    Score: 0.002
  45. Selective screening for high cholesterol in Australian general practice: the Newcastle Cholesterol Prediction Study. J Gen Intern Med. 1990 Jan-Feb; 5(1):1-8.
    View in: PubMed
    Score: 0.002
  46. Endothelin-1 is a key mediator of coronary vasoconstriction in patients with transplant coronary arteriosclerosis. Circ Heart Fail. 2009 Sep; 2(5):409-16.
    View in: PubMed
    Score: 0.002
  47. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial. J Am Coll Cardiol. 2009 Jun 09; 53(23):2186-96.
    View in: PubMed
    Score: 0.002
  48. Comparison of Reflotron and laboratory cholesterol measurements. Med J Aust. 1988 Aug 01; 149(3):126-9.
    View in: PubMed
    Score: 0.002
  49. High cholesterol levels: is mass screening the best option? Med J Aust. 1988 Jun 20; 148(12):635-7.
    View in: PubMed
    Score: 0.002
  50. Improved characterization of atherosclerotic plaques by gadolinium contrast during intravascular magnetic resonance imaging of human arteries. Atherosclerosis. 2008 Feb; 196(2):919-25.
    View in: PubMed
    Score: 0.002
  51. Regions of low endothelial shear stress are the sites where coronary plaque progresses and vascular remodelling occurs in humans: an in vivo serial study. Eur Heart J. 2007 Mar; 28(6):705-10.
    View in: PubMed
    Score: 0.002
  52. Impact of coronary endothelial function on the progression of cardiac transplant-associated arteriosclerosis: effect of anti-oxidant vitamins C and E. J Heart Lung Transplant. 2006 Apr; 25(4):426-33.
    View in: PubMed
    Score: 0.002
  53. Remodeling characteristics of minimally diseased coronary arteries are consistent along the length of the artery. Am J Cardiol. 2006 Jan 01; 97(1):13-6.
    View in: PubMed
    Score: 0.002
  54. Characterization of human atherosclerotic plaques by intravascular magnetic resonance imaging. Circulation. 2005 Oct 11; 112(15):2324-31.
    View in: PubMed
    Score: 0.002
  55. Vascular basis for the treatment of myocardial ischemia study: trial design and baseline characteristics. Am Heart J. 2004 May; 147(5):875-82.
    View in: PubMed
    Score: 0.002
  56. Reproducibility of coronary lumen, plaque, and vessel wall reconstruction and of endothelial shear stress measurements in vivo in humans. Catheter Cardiovasc Interv. 2003 Sep; 60(1):67-78.
    View in: PubMed
    Score: 0.001
  57. Effect of endothelial shear stress on the progression of coronary artery disease, vascular remodeling, and in-stent restenosis in humans: in vivo 6-month follow-up study. Circulation. 2003 Jul 29; 108(4):438-44.
    View in: PubMed
    Score: 0.001
  58. Endothelin-1 and vascular tone in subjects with atherogenic risk factors. Hypertension. 2003 Jul; 42(1):43-8.
    View in: PubMed
    Score: 0.001
  59. Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells. Circulation. 2002 Dec 03; 106(23):2888-93.
    View in: PubMed
    Score: 0.001
  60. Circulating autoantibodies to oxidized LDL correlate with impaired coronary endothelial function after cardiac transplantation. Arterioscler Thromb Vasc Biol. 2002 Dec 01; 22(12):2044-8.
    View in: PubMed
    Score: 0.001
  61. Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial. Lancet. 2002 Mar 30; 359(9312):1108-13.
    View in: PubMed
    Score: 0.001
  62. Relation of preservation of nitric oxide-dependent coronary vasomotor function to plasma vitamin C concentrations in cardiac transplant recipients. Am J Cardiol. 2000 Aug 15; 86(4):460-2.
    View in: PubMed
    Score: 0.001
  63. Effect of transient abrupt vessel closure during otherwise successful angioplasty for unstable angina on clinical outcome at six months. Hirulog Angioplasty Study Investigators. J Am Coll Cardiol. 1999 Jan; 33(1):73-8.
    View in: PubMed
    Score: 0.001
  64. Chlamydia pneumoniae infection is frequent but not associated with coronary arteriosclerosis in cardiac transplant recipients. Am J Cardiol. 1998 Dec 15; 82(12):1479-83.
    View in: PubMed
    Score: 0.001
  65. Reproducibility of brachial ultrasonography and flow-mediated dilatation (FMD) for assessing endothelial function. Aust N Z J Med. 1997 Dec; 27(6):649-52.
    View in: PubMed
    Score: 0.001
  66. Can ECG changes predict the long-term outcome in patients admitted to hospital for suspected acute myocardial infarction? Cardiology. 1997 Sep-Oct; 88(5):460-7.
    View in: PubMed
    Score: 0.001
  67. Low-risk febrile neutropenia in a medical oncology unit. Aust N Z J Med. 1997 Aug; 27(4):403-7.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.